Tongkat Ali (Eurycoma longifolia): a possible therapeutic candidate against Blastocystis sp.

Particle and Fibre Toxicology

Norhaniza Aminudin¹  Suresh Kumar²  Sonal Girish² 

[1] Institute of Biological Sciences, Faculty of Science & University of Malaya Centre for Proteomics Research, Medical Biotechnology Laboratory, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia;Department of Parasitology, Faculty of Medicine, University of Malaya, Kuala Lumpur, 50603, Malaysia

关键词: Eurycoma longifolia;    Blastocystis;    Subtypes;    Drug susceptibility assay;    Herbal extracts;    Allopathic drugs;   

Others  :  1224189
DOI  :  10.1186/s13071-015-0942-y

 received in 2015-04-09, accepted in 2015-06-08,  发布年份 2015

【 摘 要 】

Background

In the local Malaysian context, herbal plants such as Eurycoma longifolia (Tongkat Ali), Orthosiphon stamineus (MisaiKucing), Ficus deltoidea (Mas Cotek), Zingiber officinale (Halia Bara) and Barringtonia racemosa (Putat) are known and widely used for its therapeutic properties. The first part of this study aims to screen for the anti-protozoal activity of these herbal plant extracts against Blastocystis sp. isolate subtype (ST) 3. Herbal extract with the highest efficacy was further fractionized into water and ethyl acetate fractions and tested against ST1, ST3 and ST5 Blastocystis sp. isolates. These isolates were also exposed to allopathic drugs, Metronidazole (MTZ), Tinidazole, Trimethoprim-sulfamethoxazole(TMP-SMX), Ketoconazole and Nitazoxanide for comparison purpose.

Methods

Blastocystis sp. isolates from human-derived stool samples were exposed to herbal extracts and allopathic drugs at a concentration of 0.1 mg/ml and 1.0 mg/ml and were incubated at 37 °C. Growth profile studies were carried out. After 72 h of treatment, the viability of Blastocystis sp. as a result of the effects of the drugs and herbal extracts were assessed.

Results

Based on the screening process, amongst all the extracts, Tongkat Ali exhibited the highest anti-protozoal activity at 1.0 mg/ml. Between the water and ethyl acetate fractions of Tongkat Ali, the ethyl acetate fraction exhibited a slightly higher percentage of anti-protozoal activity at 1.0 mg/ml across subtypes, ST1 (94.9 %), ST3 (95.1 %) and ST5 (94.3 %). When tested with allopathic drugs, at the same concentration, MTZ exhibited the highest anti-protozoal activity across subtypes, ST1 (95.8 %), ST3 (93.4 %) and ST5 (90.8 %).

Conclusion

This study is the first to describe the anti-protozoal properties of Tongkat Ali against Blastocystis sp. isolates. Ethyl acetate fraction of Tongkat Ali demonstrated the highest anti-protozoal activity against Blastocystis sp. isolates and showed a sizeable reduction in the cell count which was comparable with MTZ. Tongkat Ali also demonstrated a more uniformed sensitivity across subtypes in comparison to the allopathic drugs.

【 授权许可】

   
2015 Girish et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Arisue N, Hashimoto T, Yoshikawa H, Nakamura Y, Nakamura G, Nakamura F, Yano TA, Hasegawa M. Phylogenetic position of Blastocystis hominis and of stramenopiles inferred from multiple molecular sequence data. J Eukaryot Microbiol. 2002; 49(1):42-53.
• [2]Stensvold CR. Blastocystis: genetic diversity and molecular methods for diagnosis and epidemiology. Trop Parasitol. 2013; 3:26-34.
• [3]Stenzel DJ, Boreham PFL. Blastocystis hominis revisited. Clin Microbiol Rev. 1996; 9:563-84.
• [4]Parkar U, Traub RJ, Vitali S, Elliot A, Levecke B, Robertson I, Geurden T, Steele J, Drake B, Thompson RC. Molecular characterization of Blastocystis isolates from zoo animals and their animal-keepers. Vet Parasitol. 2010; 169(1–2):8-17.
• [5]El Safadi D, Gaayeb L, Meloni D, Cian A, Poirier P, Wawrzyniak I, Delbac F, Dabboussi F, Delhaes L, Seck M, Hamze M, Riveau G, Viscogliosi E. Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide. BMC Infect Dis. 2014; 14(1):164. BioMed Central Full Text
• [6]Sekar U, Shanthi M. Blastocystis: consensus of treatment and controversies. Trop Parasitol. 2013; 3:35-9.
• [7]Lucia JF, Aguilar C, Betran A. Blastocystis hominis colitis in a haemophilic patient as a cause of lower gastrointestinal bleeding. Haemophilia. 2007; 13(2):224-5.
• [8]Moghaddam DD, Ghadirian E, Azami M. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/ sulfamethoxazole. Parasitol Res. 2005; 96(4):273-5.
• [9]Johnson PJ. Metronidazole and drug resistance. Parasitol Today. 1993; 9:183-6.
• [10]Voolmann Y, Boreham PFL. Metronidazole resistant Trichomonas vaginalis in Brisbane. Med J Aust. 1993; 159:490.
• [11]Nongyao S, Kitja S. The effects of extracts from anti-diarrheic Thai medicinal plants on the in vitro growth of the intestinal protozoa parasite: Blastocystis hominis. J Ethnopharmacol. 2005; 98:67-72.
• [12]Yakoob J, Abbas Z, Beg MA, Naz S, Awan S, Hamid S. In vitro sensitivity of Blastocystis hominis to garlic, ginger, white cumin, and black pepper used in diet. Parasitol Res. 2011; 109:379-85.
• [13]Farouk AE, Benafri A. Antibacterial activity of Eurycoma longifolia Jack: A Malaysian medicinal plant. Saudi Med J. 2007; 28(9):1422-4.
• [14]Jiwajinda S, Santisopasri V, Murakami A et al.. In vitro anti‐tumor promoting and antiparasitic activities of the quassinoids from Eurycoma longifolia, a medicinal plant in Southeast Asia. J Ethnopharmacol. 2002; 82:55-8.
• [15]Kuo PC, Shi LS, Damu AG, Su CR, Huang CH, Ke CH, Wu JB, Lin AJ, Bastow KF, Lee KH. Cytotoxic and antimalarial beta‐carboline alkaloids from the roots of Eurycoma longifolia. J Nat Prod. 2003; 66(10):1324-7.
• [16]Ameer OZ, Salman IM, Asmawi MZ, Ibraheem ZO, Yam MF. Orthosiphon stamineus: traditional uses, phytochemistry, pharmacology, and toxicology. J Med Food. 2012; 15(8):678-90.
• [17]Nurul Mariam H, Radzali M, Johari R, Syahida A, Maziah M. Antioxidant activities of different aerial parts of putat (Barringtonia racemosa L.). Malays J Biochem Mol Biol. 2008; 16(2):15-9.
• [18]Khan MR, Jabbar A, Hassan CM, Rahid MA. Antibacterial activity of Barringtonia racemosa. Fitoterapia. 2001; 72:162-4.
• [19]Aminudin N, Sin CY, Chee ES, Nee KI, Renxin L. Blood glucose lowering effect of Ficus deltoidea aqueous extract. Malays J Sci. 2007; 26:73-8.
• [20]Farsi E, Shafaei A, Sook YH, KhadeerAhamed BM, Mun FY, Idress HA, Zaini MA, Ismail Z. Correlation between enzymes inhibitory effects and antioxidant activities of standardized fractions of methanolic extract obtained from Ficus deltoidea leaves. Afr J Biotechnol. 2011; 10:15184-94.
• [21]Hu WY, Zhang RP, Tang LP, Liu G. Research progress in the chemical constituents and pharmacology of ginger. Chin J Ethnomed Ethnopharm. 2008; 9:10-4.
• [22]Jiang H, Xie Z, Koo HJ, McLaughlin SP, Timmermann BN, Gang DR. Metabolic profiling and phylogenetic analysis of medicinal Zingiber species: Tools for authentication of ginger (Zingiber officinale Rosc.). Phytochem. 2006; 67:232-44.
• [23]Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol. 2007; 45:683-90.
• [24]Jones WR. The experimental infection of rats with Entamoeba histolytica. Ann Trop Med Parasitol. 1946; 40:130.
• [25]Misbah H, Aziz AA, Aminudin N. Antidiabetic and antioxidant properties of Ficus deltoidea fruit extracts and fractions. BMC Complement Altern Med. 2013; 13:118. BioMed Central Full Text
• [26]Leelayoova S, Rangsin R, Taamasri P, Naaglor T, Thathaisong U, Mungthin M. Evidence of waterborne transmission of Blastocystis hominis. Am J Trop Med Hyg. 2004; 70(6):658-62.
• [27]Baldo ET, Belizario VY, De Leon WU, Kong HH, Chung DI. Infection status of intestinal parasites in children living in residential institutions in Metro Manila, the Philippines. Korean J Parasitol. 2004; 42(2):67-70.
• [28]Zaman V. Blastocystis hominis. In: Oxford Textbook of Medicine. 3rd ed. Weatherall DJ, Ledigham JGG, Warrell D, editors. Oxford University Press, Oxford; 1996: p.887.
• [29]Barahona RL, Maguina VC, Naquira VC, Terashima IA, Tello R. Human blastocystosis: prospective study symptomatology and associated epidemiological factors. Rev Gastroenterol Peru. 2003; 23:29-35.
• [30]Kuo PC, Damu AG, Lee KH, Wu TS. Cytotoxic and antimalarial constituents from the roots of Eurycoma longifolia. Bioorg Med Chem. 2004; 12(3):537-44.
• [31]Sambandan D, Yamamoto A, Fanara JJ, Mackay TFC, Anholt RRH. Dynamic genetic interactions determine odor-guided behavior in Drosophila melanogaster. Genetics. 2006; 174:1349-63.
• [32]Miyake K, Tezuka Y, Awale S, Li F, Kadota S. Quassinoids from Eurycoma longifolia. J Nat Prod. 2009; 72:2135-40.
• [33]Gutiérrez RMP. Handbook of Compounds with Antiprotozoal Activity Isolated from Plants. Nova, New York; 2007.
• [34]Ferreira ME, Rojas de Arias A, Torres de Ortiz S, Inchausti A, Nakayama H, Thouvenel C, Hocquemiller R, Fournet A. Leishmanicidal activity of two canthin-6-one alkaloids, two major constituents of Zanthoxylum chiloperone var. angustifolium. J Ethnopharmacol. 2002; 80(2–3):199-202.
• [35]Ferreira ME, Nakayama H, de Arias AR, Schinini A, de Bilbao NV, Serna E, Lagoutte D, Soriano-Agatón F, Poupon E, Hocquemiller R, Fournet A. Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi infected mice. J Ethnopharmacol. 2007; 109(2):258-63.
• [36]Kardono LBS, Angerhofer CK, Tsauri S, Padmawinata K, Pezzuto JM, Kinghorn AD. Cytotoxic and antimalarial constituents of the roots of Eurycoma longifolia. J Nat Prod. 1991; 54(5):1360-7.
• [37]Stensvold CR, Smith HV, Nagel R, Olsen KE, Traub RJ. Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol. 2010; 44(2):85-90.
• [38]Dhurga DB, Suresh KG, Tan TC, Chandramathi S. Apoptosis in Blastocystis spp. is related to subtype. Trans R Soc Trop Med Hyg. 2012; 106(12):725-30.